Knuff & CO LLC Moderna, Inc. Transaction History

Knuff & CO LLC

$296 Million
Q1 2024

A detailed history of Knuff & CO LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Knuff & CO LLC holds 5,491 shares of MRNA stock, worth $639,426. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,491

Previous 8,380 34.47%

Holding current value

$639,426

Previous $833,000 29.77%

% of portfolio

0.2%

Previous 0.3%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$85.37 - $115.44 $246,633 - $333,506	-2,889 Reduced 34.47%	5,491 $585,000
Q4 2023 Feb 06, 2024	SELL	$69.51 - $104.43 $863,105 - $1.3 Million	-12,417 Reduced 59.71%	8,380 $833,000
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $351,318 - $461,366	3,644 Added 21.24%	20,797 $2.15 Million
Q2 2023 Aug 08, 2023	BUY	$118.5 - $160.53 $29,151 - $39,490	246 Added 1.46%	17,153 $2.08 Million
Q1 2023 May 08, 2023	SELL	$135.66 - $197.02 $117,617 - $170,816	-867 Reduced 4.88%	16,907 $2.6 Million

Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $63,451 - $112,581	536 Added 3.11%	17,774 $3.19 Million
Q3 2022 Nov 04, 2022	SELL	$118.07 - $194.18 $121,139 - $199,228	-1,026 Reduced 5.62%	17,238 $2.04 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $9,136 - $13,774	78 Added 0.43%	18,264 $2.61 Million
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $94,086 - $174,877	744 Added 4.27%	18,186 $3.13 Million
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $82,875 - $135,243	367 Added 2.15%	17,442 $4.43 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $23,299 - $50,869	-105 Reduced 0.61%	17,075 $6.57 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $1.56 Million - $2.83 Million	12,038 Added 234.11%	17,180 $4.04 Million
Q1 2021 May 04, 2021	BUY	$109.18 - $185.98 $561,403 - $956,309	5,142 New	5,142 $673,000

Others Institutions Holding MRNA

# of Institutions

1,039

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knuff & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knuff & CO LLC with notifications on news.

Account